Form 4 for CDIO Cardio Diagnostics Holdings, Inc.
Accepted 2023-10-04 00:00:00 ET · period of report 2023-07-31 · accession 0001486189-23-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-10-04 | 2023-07-31+ | CDIO | Lau Stanley K. | Dir | M - OptEx | $0.3859 | +47.9K | 77.3K | +163% | +$18.5K |
| DM | 2023-10-04 | 2023-07-31+ | CDIO | Lau Stanley K. | Dir | M - OptEx | — | 0 | 12.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-30 | M | A | 5,882 | $0.34 | 40,583 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-31 | M | A | 3,637 | $0.55 | 34,701 | D | — | — | |
| 3 | Common | Common Stock | 2023-07-31 | M | A | 1,653 | $1.21 | 31,064 | D | — | — | |
| 4 | Common | Common Stock | 2023-09-30 | M | A | 36,765 | $0.34 | 77,348 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2023-09-30 | M | D | — | $0.00 | 8,000 | D | $0.00 · 2023-09-30 to 2024-01-31 | — Common Stock | (F7) The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. (F9) Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. (F6) On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024. |
| 6 | Derivative | Restricted Stock Units | 2023-08-31 | M | D | — | $0.00 | 10,000 | D | $0.00 · 2023-08-31 to 2024-01-31 | — Common Stock | (F7) The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. (F8) Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On August 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $0.5499, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. (F6) On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024. |
| 7 | Derivative | Restricted Stock Units | 2023-07-31 | M | D | — | $0.00 | 12,000 | D | $0.00 · 2023-07-31 to 2024-01-31 | — Common Stock | (F7) The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. (F5) Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $1.21, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I. (F6) On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024. |
| 8 | Derivative | Restricted Stock Units | 2023-09-30 | M | D | — | $0.00 | 12,500 | D | $0.00 · 2023-09-30 to 2023-12-31 | — Common Stock | (F7) The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan. (F10) Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On September 30, 2023, $12,500 in value of RSUs vested and were settled at the price of $0.34 which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I. (F11) On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs of which $12,500 vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the remaining $12,500 in value of RSUs will vest on December 31, 2023, based on the closing price of the Issuers common stock on the vesting date. |